Thymosin Beta-4 (Antiviral Expanded)
An expanded vendor framing of thymosin beta-4; the peptide is real, but no established direct antiviral activity supports the claims.
Overview
This is an expanded vendor framing of thymosin beta-4 under an antiviral heading. Thymosin beta-4 is a genuine endogenous peptide (see the TB-500 entry) with documented roles in wound healing and immunomodulation, but no established direct antiviral mechanism appears in the peer-reviewed literature for the peptide itself. The antiviral-expanded claims attached to this catalog listing are not supported by published evidence and are best understood as marketing categorization.